ClearPoint Neuro Inc.

Historical 13F Holders

Symbol
CLPT
CUSIP
18507C103
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 18507C103 since 12/18/2024, largest first.

Filer % of Class Filed
Mak Capital One LLC 13G/A
7.8% 8/12/2026
Event 6/30/2026
Bigger Capital Fund L P 13G/A
7.5% 8/4/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 7.1% 7/27/2026
Event 6/30/2026
MAK Capital Fund LP 13G/A
6.3% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 23.7 k $290 k
2026 Q2 138 13.9 M $248 M
2026 Q1 127 13.0 M $118 M
2025 Q4 129 11.3 M $155 M
2025 Q3 117 10.0 M $224 M
2025 Q2 105 9.46 M $113 M
2025 Q1 107 8.19 M $97.5 M
2024 Q4 95 7.60 M $117 M
2024 Q3 85 6.83 M $76.6 M
2024 Q2 94 7.15 M $38.6 M
2024 Q1 90 7.86 M $53.5 M
2023 Q4 78 6.53 M $44.4 M
2023 Q3 67 5.95 M $29.8 M
2023 Q2 64 5.81 M $42.0 M
2023 Q1 64 4.61 M $38.9 M
2022 Q4 67 4.30 M $36.6 M
2022 Q3 62 3.82 M $39.6 M
2022 Q2 54 3.48 M $45.4 M
2022 Q1 68 4.76 M $49.5 M
2021 Q4 76 4.83 M $54.2 M
2021 Q3 78 5.49 M $97.5 M
2021 Q2 85 5.36 M $102 M
2021 Q1 53 3.10 M $130 M
2020 Q4 40 2.27 M $36.1 M
2020 Q3 29 1.04 M $7.99 M
2020 Q2 29 1.14 M $4.06 M
2020 Q1 29 1.28 M $4.65 M